Octaplasma (Human Plasma Protein)

Octaplasma is employed in clinical situations that require replacement of multiple coagulation factors and plasma volume.

• Massive transfusion protocols: helps to restore clotting capacity and volume in patients receiving large volumes of blood components.
• Liver transplantation: provides balanced plasma proteins to aid coagulation during the procedure.
• Congenital coagulation factor deficiencies: supplies missing plasma‑derived factors to improve clotting.
• Cardiac surgery : supports hemostasis during and after cardiac procedures.
• Trauma‑related bleeding : contributes to rapid hemostatic control in severe injury.

• Octaplasma contains a pooled, solvent‑detergent treated plasma fraction that provides a broad spectrum of functional clotting factors, fibrinogen, albumin and protein C along with plasma proteins that contribute to normal hemostasis. The solvent‑detergent process inactivates lipid‑enveloped viruses, preserving the activity of these proteins while ensuring viral safety.

Octaplasma may elicit a range of infusion‑related reactions.

Common Side Effects

• Mild fever
• Chills
• Headache
• Nausea
• Transient hypotension
• Redness at the infusion site

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis)
• Acute hemolytic transfusion reaction
• Transfusion‑related acute lung injury (TRALI)
• Volume overload leading to pulmonary edema
• Disseminated intravascular coagulation (D血 D ).

Octaplasma should be administered with careful clinical monitoring.

• Verify patient identity and blood type: ensure compatibility before infusion.
• Assess for history of allergic reactions: watch for signs of hypersensitivity.
• Monitor vital signs during infusion: watch for hypotension or fever.
• Adjust infusion rate: slower rates may reduce reaction risk.
• Use in patients with fluid overload risk: consider diuretics or alternative products.
• Store at 2-8°C: keep refrigerated ; protect from light and do not freeze.

Octaplasma may interact with other blood products and medications that affect coagulation.

Major Interactions (Avoid)

• Concomitant use of high‑dose anticoagulants (e.g., unfractionated heparin) may increase bleeding risk.
• Concurrent treatment with pro‑  

g   g  \